Barry Stein had ignored symptoms that started appearing in 1995. Now he's committed to helping people recognize the signs of ...

Results of multi-institutional clinical study published in peer reviewed journal ‘Cancers’ confirms efficacy of Oxford BioDynamics’ EpiSwitch® blood-based Colorectal No-Stool Test (NST) Discussions ...

Medical device firm Creo Medical Group said on Thursday that the Aneurin Bevan University Health Board had initiated a ...

Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...

This investigation was initiated to determine whether NAFLD has a relationship to colorectal adenomatous polyps. Results: The prevalence of NAFLD was 41.5% in the adenomatous polyp group and 30.2% ...

Aneurin Bevan University Health Board (ABUHB) has become the first in Wales to pilot a groundbreaking technology transforming ...

Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal ...

St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.

CHENNAI: Ever wondered how digestion happens in the body? The food we eat transverse through four tubes — the oesophagus, ...

A health board has become the first in Wales to implement a technology to treat Colon cancer, developed by Welsh med-tech company Creo Medical.

THE NHS in the Gwent region has become the first place in Wales to pilot a new non-invasive procedure for colon cancer. Aneurin Bevan University Health Board (ABUHB) has started using the speedboat ...

On detection of diminutive polyps (defined as measuring ≤ 5 mm), further assessment with hWLE followed by NBI was performed. These assessments were digitally recorded (high-definition video ...